Deciphera Pharmaceuticals LLC (DCPH)

NASDAQ
18.10
-0.47(-2.53%)
After Hours
17.50
-0.60(-3.31%)
- Real-time Data
  • Volume:
    775,565
  • Day's Range:
    17.62 - 18.56
  • 52 wk Range:
    6.51 - 37.99

DCPH Overview

Prev. Close
18.57
Day's Range
17.62-18.56
Revenue
100.21M
Open
18.44
52 wk Range
6.51-37.99
EPS
-4.07
Volume
775,565
Market Cap
1.21B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
881,087
P/E Ratio
-4.22
Beta
1.1
1-Year Change
-45.74%
Shares Outstanding
66,822,086
Next Earnings Date
Nov 09, 2022
What is your sentiment on Deciphera Pharma?
or
Market is currently closed. Voting is open during market hours.

Deciphera Pharmaceuticals LLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Deciphera Pharmaceuticals LLC Analysis

Deciphera Pharmaceuticals LLC Company Profile

Deciphera Pharmaceuticals LLC Company Profile

Employees
350

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and delivering medicines to patients for the treatment of cancer. The Company has developed a switch-control kinase inhibitor platform in kinase biology to execute its strategy to develop a broad portfolio of medicines. The Company has one approved drug, QINLOCK, which is a switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). In addition, the Company is developing three clinical-stage drug candidates, which includes Vimseltinib (DCC-3014) - colony stimulating factor 1 receptor (CSF1R) Kinase Inhibition for Tenosynovial Giant Cell Tumor (TGCT), Rebastinib - TEK tyrosine kinase (TIE2) Kinase Inhibition for advanced or Metastatic Solid Tumors, and DCC-3116 - ULK Kinase Inhibition for Mutant RAS/RAF Cancers.

Read More

Analyst Price Target

Average10.78 (-40.45% Downside)
High15
Low6
Price18.1
No. of Analysts9
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellBuySell
Technical IndicatorsStrong BuyStrong BuyStrong SellNeutralStrong Sell
SummaryStrong BuyBuyStrong SellNeutralStrong Sell
  • interesting day, new offering on the shirt tails of the path to august, hmmm
    0
    • 2 pipelines heading to approval
      0